132 related articles for article (PubMed ID: 11840286)
1. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.
Naoe T; Tagawa Y; Kiyoi H; Kodera Y; Miyawaki S; Asou N; Kuriyama K; Kusumoto S; Shimazaki C; Saito K; Akiyama H; Motoji T; Nishimura M; Shinagawa K; Ueda R; Saito H; Ohno R
Leukemia; 2002 Feb; 16(2):203-8. PubMed ID: 11840286
[TBL] [Abstract][Full Text] [Related]
2. [The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia].
Zhang Y; Yang L; Li R; Zhang L; Zhang MR; Xiao ZJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):213-6. PubMed ID: 16624155
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia.
Davies SM; Robison LL; Buckley JD; Tjoa T; Woods WG; Radloff GA; Ross JA; Perentesis JP
J Clin Oncol; 2001 Mar; 19(5):1279-87. PubMed ID: 11230469
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy.
Mossallam GI; Abdel Hamid TM; Samra MA
J Egypt Natl Canc Inst; 2006 Sep; 18(3):264-73. PubMed ID: 17671537
[TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia).
Rimando MG; Chua MN; Yuson Ed; de Castro-Bernas G; Okamoto T
Biosci Rep; 2008 Jun; 28(3):117-24. PubMed ID: 18444911
[TBL] [Abstract][Full Text] [Related]
7. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
[TBL] [Abstract][Full Text] [Related]
9. [Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia].
Liu L; Yang L; Zhang Y; Xu ZF; Yu MH; Wang JX; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):378-82. PubMed ID: 18581889
[TBL] [Abstract][Full Text] [Related]
10. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia.
Crump C; Chen C; Appelbaum FR; Kopecky KJ; Schwartz SM; Willman CL; Slovak ML; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):457-60. PubMed ID: 10815689
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
15. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
16. GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis.
Xiao Q; Deng D; Li H; Ye F; Huang L; Zhang B; Ye B; Mo Z; Yang X; Liu Z
Ann Hematol; 2014 Aug; 93(8):1381-90. PubMed ID: 24994605
[TBL] [Abstract][Full Text] [Related]
17. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
[TBL] [Abstract][Full Text] [Related]
18. Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.
Eyada TK; El Ghonemy EG; El Ghoroury EA; El Bassyouni SO; El Masry MK
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):489-95. PubMed ID: 17581325
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
[TBL] [Abstract][Full Text] [Related]
20. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome.
Medeiros R; Pereira D; Afonso N; Palmeira C; Faleiro C; Afonso-Lopes C; Freitas-Silva M; Vasconcelos A; Costa S; Osório T; Lopes C
Int J Clin Oncol; 2003 Jun; 8(3):156-61. PubMed ID: 12851839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
